532
Views
20
CrossRef citations to date
0
Altmetric
Original Research

The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile

, , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & show all
Pages 997-1010 | Published online: 15 Nov 2019

Figures & data

Figure 1 Venn diagram of data-generating and study cohorts.

Figure 1 Venn diagram of data-generating and study cohorts.

Table 1 Overview Of Definitions And Rationale For The Three Study Cohorts Of The ERASE Project

Table 2 Cumulative Frequencies Of Persons Included In The Expanded Cohort By Data Source

Table 3 Cumulative Frequencies Of First-Ever Acute Rheumatic Fever (ARF) Diagnosis Dates In The Expanded Cohort, By Data Source

Table 4 Cumulative Frequencies Of Rheumatic Heart Disease (RHD) Onset Dates In The Expanded Cohort, By Data Source

Figure 2 Age distribution of cases at time of initial (A). Acute rheumatic fever (ARF) and (B). Rheumatic heart disease (RHD) diagnoses, by Indigenous status (2001–2017, mid-year).

Figure 2 Age distribution of cases at time of initial (A). Acute rheumatic fever (ARF) and (B). Rheumatic heart disease (RHD) diagnoses, by Indigenous status (2001–2017, mid-year).

Table 5 Descriptive Profile Of Study Cohorts For Patients Under 60 Years At The Time Of First ARF Or RHD Diagnosis, N (%)

Figure 3 Geographical distribution of the Indigenous (A) and non-Indigenous (B) population diagnosed with either acute rheumatic fever or rheumatic heart disease at the time of the first diagnosis.

Figure 3 Geographical distribution of the Indigenous (A) and non-Indigenous (B) population diagnosed with either acute rheumatic fever or rheumatic heart disease at the time of the first diagnosis.

Data Availability

The ERASE database cannot be shared publicly. Australian-based researchers can apply to the ERASE Project team with a proposal to analyze a pertinent research question using the ERASE Project data, subject to internal and ethics approval of the investigator and their research plans.